Indian pharmaceutical market will reach 55 billion in 2020

Feb 23
08:23

2012

David Yvon

David Yvon

  • Share this article on Facebook
  • Share this article on Twitter
  • Share this article on Linkedin

The size of the Indian pharmaceutical market in 2009 was $ 12.6 billion, which means that in 2020 it will increase by four times.

mediaimage

If India continues to maintain growth efforts,Indian pharmaceutical market will reach 55 billion in 2020  Articles in 2020 it may reach $ 70 billion. BRIC (Brazil, Russia, India and China) will become leaders in the pharmaceutical market in next 10 years.

In the past five years, the Indian pharmaceutical industry growth rate of 13% to 14%, significantly higher than the 2000-2005 9 percent growth rate. According to the report, in 2010, five kinds of new opportunities for 45% plant extracts market share, increased from the current $ 3 billion to 14 billion to $ 18 billion, including the patented product, consumers of health care, biological products, vaccines, and public Health. In addition, epidemiological factors lead to the increase in patient population, for basic medical research investments to increase the application of the drug caused an increase in the large number of new drugs and the burden on patient’s ability, these are the driving force of the pharmaceutical market.

As people's incomes and insurance coverage to expand to make medicines to spend to reduce the affordability of the patient's pharmaceutical market growth expected to play half the role. To 2020, the revenue increase will be India's middle and upper income groups increased to 70 million, at the same time, health insurance coverage will reach 650 million people, the growth rate to 15% of the private insurance, government-sponsored plans, many the underlying populations will be guaranteed.

When the burden ability on patients to promote increase the pharmaceutical chia seed market, pharmaceutical companies should actively enhance the ability of exposure to modern medicine. In the past five years, the Indian pharmaceutical industry is also faced with many challenges. Discontinuities and economic changes in the structure of the development of the health sector in India to become the greatest challenge.

The India government needs to play an active role in order to ensure the healthy development of the pharmaceutical industry. Now it has become a consensus. India should increase investment in health and achieve 3% of GDP. At the same time, India ought to increase investment of the medical and health care in rural areas and the second phase. Taking measures of health care spending and increasing the number of doctors will become policies to help the healthy development of the entire pharmaceutical industry.Source:http://www.cospcn.com